<DOC>
	<DOCNO>NCT00854776</DOCNO>
	<brief_summary>Studies show combined use clopidogrel aspirin 25 % reduction risk myocardial infarction stroke patient undergone percutaneous coronary intervention ( PCI ) compare use aspirin alone . However , major GI bleeding rise combined group aspirin group . Use proton pump inhibitor ( PPI ) diminish gastric acid secretion effectively reduce aspirin clopidogrel associate ulcer or/and ulcer bleed general population high risk patient . The investigator hypothesis whether use PPI reduce ulcer ulcer complication patient take clopidogrel aspirin .</brief_summary>
	<brief_title>Peptic Ulcer Disease Ischemic Heart Patients Taking Aspirin Clopidogrel With Without Proton Pump Inhibitor</brief_title>
	<detailed_description>Patients eligible receive PCI stenotic coronary artery . Patients past history PUD without complication , take aspirin clopidogrel enrol CV disease allow enroll . Patients exclude New York Heart Association class IV heart failure , contraindication antithrombotic antiplatelet therapy , clinical severe thrombocytopenia ( platelet count &lt; 80000/mm3 ) , previous disabling , hemorrhagic stroke intracranial hemorrhage , severe unstable condition hepatic , renal , pulmonary disease , unstable progressive malignancy , epigastralgia positive occult blood stool , current recent peptic ulcer disease take PPI histamine receptor-2 antagonist without prove heal ulcer scopy , receive surgical intervention due ulcer complication ( bleeding , perforation , obstruction ) past . Patient randomly assign aspirin ( 100 mg/day ) plus clopidogrel ( 75 mg/day ) PPI ( lansoprazole-Takepron @ 30 mg/day ) aspirin ( 100 mg/day ) plus clopidogrel ( 75 mg/day ) placebo ( antacid 1 table/day ) 3 month . Patients follow outpatient , visit every one month , check blood hemoglobin well stool occult blood 3 months.Patients ask report gastroenterologist persistent ulcer symptom ( epigastric pain , dyspepsia ) report emergency room evidence GI bleed ulcer complication ( melena , hematemesis , sudden onset severe epigastric pain ) . Endoscopy undergone document gastroduodenal ulcer without ulcer complication . Patients without persistent ulcer symptom without evidence ulcer complication invite undergone schedule endoscopy 3-month end follow-up.The primary end point occurrence clinical upper GI event ( symptomatic ulcer ulcer complications-bleeding , perforation , obstruction ) . The secondary end point occurrence dyspepsia , asymptomatic gastroduodenal ulcer .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>Patients eligible receive PCI stenotic coronary artery take aspirin clopidogrel . Patients past history PUD without complication , take aspirin clopidogrel enrol CV disease allow enroll . Patients exclude New York Heart Association class IV heart failure , contraindication antithrombotic antiplatelet therapy , clinical severe thrombocytopenia ( platelet count &lt; 80000/mm3 ) , previous disabling , hemorrhagic stroke intracranial hemorrhage , severe unstable condition hepatic , renal , pulmonary disease , unstable progressive malignancy , epigastralgia positive occult blood stool , current recent PUD take PPI histamine receptor2 antagonist without prove heal ulcer scopy , receive surgical intervention due PUD complication ( bleeding , perforation , obstruction ) past , receive GP IIb/IIIa inhibitor few 3 day randomization .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>peptic ulcer</keyword>
	<keyword>ulcer complication</keyword>
</DOC>